Leading the way in Europe to bring
microbiome-based innovations to market.
European Microbiome Innovation for Health (EMIH) brings together innovative leading European stakeholders dedicated to advancing the microbiome industry.
Our mission
The goal of the EMIH is to promote medical innovation, based on the microbiota, as one of the public health priorities within the European Union. Its members are committed to developing advances in therapeutic, diagnostics and medical bioproduction based on the microbiota, in the field of human health, through a framework meeting the highest quality standards and also allowing economic balance, in order to maintain therapeutic innovation.
About us
EMIH gathers more than 20 key private and public players supporting each other’s efforts to develop tomorrow’s medicine based on microbiome diagnostic and therapeutic innovations.
EMIH is collectively building a dynamic ecosystem to advance medical innovation centered on the microbiota, prioritizing public health within the EU and addressing unmet medical needs to enhance the quality of life for millions of patients.
Our members
EMIH brings together more than 20 key private and public players committed to develop tomorrow’s medicine based on microbiome diagnostic and therapeutic innovations.
Join us!
Unity is strength. Joining EMIH means being able to provide input to policy makers, patients’ associations, investors in Europe, and share networking opportunities while contributing to structure the industry.
News
EMIH is a partner of the 8th edition of the Microbiota and Health Day organized by Lyonbiopôle Auvergne-Rhône-Alpes.
> READ
European Microbiome Innovation for Health and Microbiome Therapeutics Innovation Group join forces with Microbiome Times on important deal-making event, taking place Brussels 2025
> READ
European Microbiome Innovation for Health and Microbiome Therapeutics Innovation Group Announce New Collaboration Agreement
> READ